Bruker Introduces Innovative Fourier 80 Multinuclear Benchtop FT-NMR
Bruker has unveiled its innovative Fourier 80 multinuclear benchtop FT-NMR spectrometer at the Joint ENC-ISMAR Conference 2025. The new 'Multi-Talent' configuration represents a significant advancement in permanent magnet-based FT-NMR technology.
The system's key features include:
- Capability to measure or decouple 1H and select from 15 different X-nuclei
- Support for X{1H} experiments and 1H{X} experiments
- Enables various 2D experiments and inverse 1H observation methods
- Includes gradient spectroscopy with options for adjustable sample temperature and sample changer automation
- Uses standard 5 mm NMR samples
According to Dr. Agnes Haber, Fourier 80 Product Manager, twelve systems have already been successfully installed in customer labs. The system is particularly valuable for pharmaceutical research and battery development, supporting observations of nuclei like 7Li, 23Na, and 11B for battery electrolyte formulation.
Bruker ha presentato il suo innovativo spettrometro FT-NMR benchtop multinucleare Fourier 80 alla Conferenza Congiunta ENC-ISMAR 2025. La nuova configurazione 'Multi-Talent' rappresenta un significativo progresso nella tecnologia FT-NMR basata su magneti permanenti.
Le caratteristiche principali del sistema includono:
- Capacità di misurare o disaccoppiare 1H e selezionare tra 15 diversi nuclei X
- Supporto per esperimenti X{1H} ed esperimenti 1H{X}
- Abilita vari esperimenti 2D e metodi di osservazione inversa 1H
- Include spettroscopia a gradiente con opzioni per temperatura del campione regolabile e automazione del cambio campione
- Utilizza campioni NMR standard da 5 mm
Secondo la Dott.ssa Agnes Haber, Product Manager di Fourier 80, dodici sistemi sono già stati installati con successo nei laboratori dei clienti. Il sistema è particolarmente prezioso per la ricerca farmaceutica e lo sviluppo di batterie, supportando osservazioni di nuclei come 7Li, 23Na e 11B per la formulazione degli elettroliti delle batterie.
Bruker ha presentado su innovador espectrómetro FT-NMR de banco multinuclear Fourier 80 en la Conferencia Conjunta ENC-ISMAR 2025. La nueva configuración 'Multi-Talent' representa un avance significativo en la tecnología FT-NMR basada en imanes permanentes.
Las características clave del sistema incluyen:
- Capacidad para medir o desacoplar 1H y seleccionar entre 15 núcleos X diferentes
- Soporte para experimentos X{1H} y experimentos 1H{X}
- Permite varios experimentos 2D y métodos de observación inversa 1H
- Incluye espectroscopia de gradiente con opciones para temperatura de muestra ajustable y automatización del cambiador de muestras
- Utiliza muestras NMR estándar de 5 mm
Según la Dra. Agnes Haber, Gerente de Producto de Fourier 80, ya se han instalado con éxito doce sistemas en laboratorios de clientes. El sistema es particularmente valioso para la investigación farmacéutica y el desarrollo de baterías, apoyando observaciones de núcleos como 7Li, 23Na y 11B para la formulación de electrolitos de baterías.
브루커가 2025년 공동 ENC-ISMAR 컨퍼런스에서 혁신적인 포리에 80 다핵 벤치탑 FT-NMR 분광계를 공개했습니다. 새로운 '멀티-탤런트' 구성은 영구 자석 기반 FT-NMR 기술의 중요한 발전을 나타냅니다.
시스템의 주요 특징은 다음과 같습니다:
- 1H를 측정하거나 분리하고 15개의 다양한 X-핵 중에서 선택할 수 있는 능력
- X{1H} 실험 및 1H{X} 실험 지원
- 다양한 2D 실험 및 역 1H 관찰 방법을 가능하게 함
- 조정 가능한 샘플 온도 및 샘플 체인저 자동화 옵션이 포함된 기울기 분광법
- 표준 5mm NMR 샘플 사용
포리에 80의 제품 관리자 아그네스 하버 박사에 따르면, 이미 고객 실험실에 12개의 시스템이 성공적으로 설치되었습니다. 이 시스템은 특히 제약 연구 및 배터리 개발에 유용하며, 배터리 전해질 조성을 위한 7Li, 23Na 및 11B와 같은 핵 관찰을 지원합니다.
Bruker a dévoilé son innovant spectromètre FT-NMR de table multinucleaire Fourier 80 lors de la Conférence conjointe ENC-ISMAR 2025. La nouvelle configuration 'Multi-Talent' représente une avancée significative dans la technologie FT-NMR basée sur des aimants permanents.
Les principales caractéristiques du système incluent:
- Capacité à mesurer ou à découpler 1H et à choisir parmi 15 noyaux X différents
- Soutien aux expériences X{1H} et aux expériences 1H{X}
- Permet diverses expériences 2D et des méthodes d'observation inverse 1H
- Comprend la spectroscopie par gradient avec des options pour la température de l'échantillon réglable et l'automatisation du changement d'échantillon
- Utilise des échantillons NMR standard de 5 mm
Selon Dr. Agnes Haber, responsable produit de Fourier 80, douze systèmes ont déjà été installés avec succès dans les laboratoires des clients. Le système est particulièrement précieux pour la recherche pharmaceutique et le développement de batteries, soutenant les observations de noyaux tels que 7Li, 23Na et 11B pour la formulation d'électrolytes de batterie.
Bruker hat auf der gemeinsamen ENC-ISMAR-Konferenz 2025 sein innovatives multinukleares benchtop FT-NMR-Spektrometer Fourier 80 vorgestellt. Die neue 'Multi-Talent'-Konfiguration stellt einen bedeutenden Fortschritt in der FT-NMR-Technologie auf der Basis von Permanentmagneten dar.
Die Hauptmerkmale des Systems umfassen:
- Fähigkeit zur Messung oder Entkopplung von 1H und Auswahl aus 15 verschiedenen X-Kernen
- Unterstützung für X{1H}-Experimente und 1H{X}-Experimente
- Ermöglicht verschiedene 2D-Experimente und inverse 1H-Beobachtungsmethoden
- Beinhaltet Gradienten-Spektroskopie mit Optionen für einstellbare Proben-Temperatur und Automatisierung des Probenwechsels
- Verwendet Standard-NMR-Proben mit 5 mm
Laut Dr. Agnes Haber, Produktmanagerin von Fourier 80, wurden bereits zwölf Systeme erfolgreich in den Laboren von Kunden installiert. Das System ist besonders wertvoll für die pharmazeutische Forschung und die Batterieforschung, da es Beobachtungen von Kernen wie 7Li, 23Na und 11B zur Formulierung von Batterieelektrolyten unterstützt.
- Launch of next-generation FT-NMR technology with enhanced versatility
- Successfully installed 12 systems in customer labs
- Expanded capabilities for pharmaceutical and battery research applications
- Software-controlled operation eliminates need for manual NMR probe tuning
- None.
Insights
Bruker's new Fourier 80 'Multi-Talent' represents a significant technical advancement in benchtop NMR technology. The key innovation is its ability to measure 15 different X-nuclei with software-based selection, eliminating the need for manual probe tuning and matching—a notable convenience improvement over conventional systems.
This product strategically targets two high-value research segments: pharmaceutical development (through enhanced capabilities for studying fluorinated drug compounds) and battery research (by enabling analysis of lithium, sodium and boron for electrolyte formulation). Both markets represent substantial growth opportunities as pharma companies accelerate drug discovery efforts and battery technologies face intense development pressure.
The system's versatility is particularly compelling—combining proton NMR capabilities with multi-nuclear observation, 2D experiments, and inverse observation methods in a permanent magnet-based platform. This expands the application scope while maintaining the smaller footprint and lower operating costs of benchtop instruments.
The mention of twelve successful installations indicates initial market validation, though this represents a modest installed base. Bruker's positioning as the "new de facto standard" suggests confidence in the product's competitive differentiation, but will require substantial market adoption to fulfill.
For Bruker investors, this represents incremental portfolio strengthening in their analytical instrumentation business, addressing specialized but valuable research markets with proprietary technology that appears to leapfrog current benchtop NMR capabilities.
Unique Fourier 80 ‘Multi-Talent’ offers 1H NMR and choice of 15 X-nuclei with just one click
ASILOMAR, Calif.--(BUSINESS WIRE)-- At the Joint ENC-ISMAR Conference 2025, Bruker Corporation, the leading provider of Nuclear Magnetic Resonance (NMR) spectroscopy solutions, announced the launch of an innovative Fourier 80 multinuclear benchtop FT-NMR spectrometer, known as the ‘Multi-Talent’ configuration. This novel Fourier 80 ‘Multi-Talent’ system represents a major advancement in permanent magnet-based FT-NMR technology, as its unique, next-generation capabilities meet the evolving needs of academic researchers and industry scientists with dramatically enhanced versatility in benchtop FT-NMR multinuclear analysis.

Novel multinuclear benchtop Fourier 80 ‘Multi-Talent’ with optional sample changer automation
The Fourier 80 ‘Multi-Talent’ system measures or decouples 1H, and in addition can select one of 15 different X-nuclei to be either observed in X{1H} experiments, or selected X-nuclei can be decoupled for proton observation in 1H{X} experiments. This enables many types of X-nucleus observations, various 2D experiments, and importantly also the exquisitely sensitive inverse 1H observation methods for 13C, 19F or 15N experiments.
Similarly, the Fourier 80 ‘Multi-Talent’ can observe 19F{1H} with proton decoupling for the simplification of 19F spectra, a capability of high interest to pharmaceutical customers studying fluorinated drug candidates. For battery research, the Fourier 80 ‘Multi-Talent’ enables nuclei observations from Li-brine mining, like 7Li, 23Na, and 11B for the formulation of battery electrolytes. Novel electrochemical systems can be explored to advance next generation battery technologies. These unprecedented benchtop capabilities are selectable via software, eliminating the need for NMR probe tuning and matching.
The ‘Multi-Talent’ uses standard 5 mm NMR samples, includes gradient spectroscopy, with options for adjustable sample temperature (AT), or sample changer automation. The user-friendly Fourier 80 interface ensures that novice and experienced users can navigate through measurements effortlessly, streamlining complex tasks and enhancing productivity.
Dr. Agnes Haber, the Fourier 80 Product Manager at Bruker BioSpin, stated: "The Fourier 80 ‘Multi-Talent’ represents a game-changing advancement in benchtop FT-NMR, with next-generation multinuclear capabilities addressing the demand for a versatile system for 1H-NMR, plus an unprecedented choice of fifteen X-nuclei, with ease, and even under automation. We have already successfully installed a dozen Fourier 80 multinuclear systems in customer labs, and we anticipate that this novel system may become the new de facto standard in benchtop multinuclear NMR spectroscopy."
About Bruker Corporation – Leader of the Post-Genomic Era (Nasdaq: BRKR)
Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research, in applied and biopharma applications, in microscopy and nanoanalysis, as well as in industrial and cleantech research, and next-gen semiconductor metrology in support of AI. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit www.bruker.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250407545969/en/
Investor Contact:
Joe Kostka
Director - Investor Relations
Bruker Corporation
T: +1 (978) 313-5800
E: Investor.Relations@bruker.com
Media Contact:
Markus Ziegler
Sr. Director and Head of Group Marketing
Bruker BioSpin
T: +49 172 373-3531
E: pr@bruker.com
Source: Bruker Corporation